Using 3D ultrasound to improve brain tumor surgery
Evaluation of 3D Ultrasound in Brain Tumor Surgery
NA · University of Ulm · NCT05956977
This study is testing whether using 3D ultrasound during brain tumor surgery can help doctors remove more of the tumor and improve patient outcomes.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 90 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University of Ulm (other) |
| Locations | 2 sites (Tübingen, Baden Würtemberg and 1 other locations) |
| Trial ID | NCT05956977 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of 3D ultrasound technology in enhancing the surgical resection of brain tumors. It aims to determine how the use of this imaging technique impacts the extent of tumor removal, as well as secondary outcomes such as neurological results, accuracy, and image quality. Participants will undergo surgery with the assistance of 3D ultrasound, while a control group will consist of patients from a retrospective matched pair cohort. The study focuses on patients with suspected intra-axial lesions, including metastasis or glioma.
Who should consider this trial
Good fit: Ideal candidates are adults over 18 years old with suspected intra-axial lesions who are eligible for potential gross total resection.
Not a fit: Patients who are unable to provide informed consent will not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could lead to more complete tumor resections and improved neurological outcomes for patients undergoing brain surgery.
How similar studies have performed: While the use of ultrasound in surgery is established, the specific application of 3D ultrasound in brain tumor surgery is relatively novel and has not been extensively tested in prior studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * age above 18 suspected intra-axial lesion (metastasis or Glioma) potential gross total resection of lesion Exclusion Criteria: * no ability for informed consent
Where this trial is running
Tübingen, Baden Würtemberg and 1 other locations
- University of Tübingen — Tübingen, Baden Würtemberg, Germany (RECRUITING)
- University of Ulm — Ulm, Germany (RECRUITING)
Study contacts
- Study coordinator: Jan Coburger, apl. Prof. Dr. med.
- Email: jan.coburger@uni-ulm.de
- Phone: 0822196
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Residual Tumor